Please assess the completion status of the following clinical trial:

Trial Title: Donor Human Milk in Neonatal Abstinence Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Term infants (\>37 completed weeks) with a diagnosis of NAS, due to maternal use of opiates (only)~* Infants will have had moderate to severe NAS symptoms (Finnegan scores \>8) that required pharmacologic therapy but have been stabilized (captured) on oral morphine (Finnegan scores less than 8 for 24 hours)~* Breastfeeding is contraindicated or the mother has chosen formula feeding for her baby~Exclusion Criteria:~* Preterm infants (\<37 completed weeks at birth)~* Infants with intrauterine growth restriction (BW \<10th percentile for gestational age)~* Mother is providing her own milk

- Gender: ALL
- Minimum Age: 38 Weeks
- Maximum Age: 42 Weeks
- Healthy Volunteers: f

Study Arms:
- DHM (Type: None): Infants identified with neonatal abstinence syndrome requiring pharmacologic management and who will not be fed own mother's milk

Based on this trial design, predict the completion outcome and termination type (if applicable).